Study protocol of a single-arm phase 2 study evaluating the preventive effect of topical hydrocortisone for capecitabine-induced hand-foot syndrome in colorectal cancer patients receiving adjuvant chemotherapy with capecitabine plus oxaliplatin (T-CRACC study)

Peer Review reports

Original Submission
3 May 2022	Submitted	Original manuscript
23 May 2022	Reviewed	Reviewer Report - Yoshihiro Okita
24 May 2022	Reviewed	Reviewer Report - Chihiro Kosugi
24 May 2022	Reviewed	Reviewer Report
1 Jun 2022	Author responded	Author comments - Yohei Iimura
Resubmission - Version 2
1 Jun 2022	Submitted	Manuscript version 2
17 Jun 2022	Author responded	Author comments - Yohei Iimura
Resubmission - Version 3
17 Jun 2022	Submitted	Manuscript version 3
Publishing
3 Jul 2022	Editorially accepted
14 Jul 2022	Article published	10.1186/s12876-022-02411-w

Back to article page